MULTIPLE SYSTEM ATROPHY (MSA)
Clinical trials for MULTIPLE SYSTEM ATROPHY (MSA) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY (MSA) trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY (MSA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for MSA: new drug aims to slow rare brain disease
Disease control Recruiting nowThis study tests a new drug called MSA-01 to see if it can slow the worsening of multiple system atrophy (MSA), a rare and serious brain disease. About 140 people with MSA will get either MSA-01 or a placebo for 12 months. The main goal is to measure changes in movement and daily…
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Phase: PHASE3 • Sponsor: Tokyo University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New protein therapy hopes to repair brain damage in rare disease
Disease control Recruiting nowThis early-phase trial tests a drug called Aleeto, a nerve repair protein made from stem cells, in 20 people with Multiple System Atrophy (MSA), a rare brain disease. The study checks if Aleeto is safe and might help with symptoms. Participants receive the drug via injection into…
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Phase: EARLY_PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC
-
New brain scan tracer could spot Parkinson's and related disorder
Diagnosis Recruiting nowThis early-stage study tests a new radioactive tracer called SST001 that lights up on PET scans. Researchers want to see if it is safe and can help tell the difference between multiple system atrophy (MSA) and Parkinson's disease. The study will include 30 healthy volunteers and …
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Phase: PHASE1 • Sponsor: Synusight Biotech (Shanghai) Co., Ltd. • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
New PET tracer aims to spot Parkinson's in the brain
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [¹⁸F]MODAG-009 to see if it can safely highlight abnormal protein clumps in the brains of people with Parkinson's disease or multiple system atrophy (MSA). About 13 participants, including healthy volunteers, will recei…
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Phase: EARLY_PHASE1 • Sponsor: MODAG GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New PET tracer aims to spot Parkinson's protein in the brain
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [18F]ACI-15916, designed to detect clumps of α-synuclein protein in the brain using PET scans. These protein deposits are linked to Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. The trial …
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Phase: EARLY_PHASE1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Can a multidisciplinary clinic improve life for MSA patients?
Knowledge-focused Recruiting nowThis study follows 200 people with Multiple System Atrophy (MSA) to see if receiving care from a team of specialists every four months improves their quality of life and eases the burden on their caregivers. Participants and their doctors will complete questionnaires about daily …
Matched conditions: MULTIPLE SYSTEM ATROPHY (MSA)
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC